Insiders / Dunn Edmund / Activity
Activity — Dunn Edmund
8 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Sell | GLUE Monte Rosa Therapeutics, Inc. Common Stock | $2.5K | -139 -0.61% | 22,554 0.03% of shares | low |
| Mar 2, 2026 | Exercise | GLUE Monte Rosa Therapeutics, Inc. Common Stock | $7.2K | +536 +2.36% | 23,229 0.03% of shares | low |
| Mar 2, 2026 | Sell | GLUE Monte Rosa Therapeutics, Inc. Common Stock | $9.4K | -536 -2.31% | 22,693 0.03% of shares | low |
| Jan 5, 2026 | Sell | GLUE Monte Rosa Therapeutics, Inc. Common Stock | $15.8K | -1K -4.38% | 22,693 0.03% of shares | low |
| Feb 27, 2026 | Exercise | GLUE Monte Rosa Therapeutics, Inc. Common Stock | $337.4K | +25K +110.89% | 47,857 0.06% of shares | low |
| Feb 27, 2026 | Sell | GLUE Monte Rosa Therapeutics, Inc. Common Stock | $455.5K | -25K -52.58% | 22,693 0.03% of shares | medium |
| Mar 2, 2026 | Exercise | GLUE Monte Rosa Therapeutics, Inc. Stock Option (Right to Buy) | — | -536 -100.00% | 0 0.00% of shares | low |
| Feb 27, 2026 | Exercise | GLUE Monte Rosa Therapeutics, Inc. Stock Option (Right to Buy) | — | -25K -97.91% | 536 <0.01% of shares | low |